ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
FTSE 100
8,819.24
-0.27%
Dow Jones
42,171.66
-0.10%
Gold vs US Dollar
3,369.05
-0.18%
Brent Oil
76.87
2.38%
Bitcoin
104,499.99
-0.39%
Pepperstone
AdvertisementAdvertisement
Registration Strip Icon for ddt Track real-time Director Deals activity on the London Stock Exchange (LSE)
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Akero Therapeutics (1AKRO) Share Price

1AKRO Akero Therapeutics

47.93
0.00 (0.00%)
Last Updated: 01:00:00
15 min delayed - Upgrade to Realtime
Share Name Share Symbol Market Type
Akero Therapeutics BIT:1AKRO Italy Ordinary Share
  Price Change % Change Share Price Shares Traded Last Trade
Upgrade Icon
  0.00 0.00% 47.93 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations USD USD -252.06M USD -3.6112 -15.20 3.35B
Last Trade Time Trade Type Trade Size Trade Price Currency
- 0 47.93 EUR

Akero Therapeutics (1AKRO) Latest News

Akero Therapeutics News

Date Time Source Headline
11/5/202508:21UKREGAkero Therapeutics et HistoIndex présentent de nouvelles analyses de..
11/5/202508:21UKREGAkero Therapeutics und HistoIndex präsentieren neue Analysen der..
10/5/202517:28UKREGAkero Therapeutics präsentiert auf dem EASL-Kongress 2025 die Ergebnisse..
10/5/202517:28UKREGAkero Therapeutics présente les résultats de la 96e semaine de l’essai..
10/5/202515:28UKREGAkero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New..
10/5/202515:28UKREGAkero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY..
10/5/202515:00UKREGAkero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY..
09/5/202512:41UKREGAkero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical..
09/5/202512:11UKREGAkero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the..

Akero Therapeutics (1AKRO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Akero Therapeutics Frequently Asked Questions (FAQ)

What is the current Akero Therapeutics share price?
The current share price of Akero Therapeutics is 47.93 €
How many Akero Therapeutics shares are in issue?
Akero Therapeutics has 69,799,000 shares in issue
What is the market cap of Akero Therapeutics?
The market capitalisation of Akero Therapeutics is EUR 3.35B
What is the 1 year trading range for Akero Therapeutics share price?
Akero Therapeutics has traded in the range of 33.80 € to 48.88 € during the past year
What is the PE ratio of Akero Therapeutics?
The price to earnings ratio of Akero Therapeutics is -15.2
What is the reporting currency for Akero Therapeutics?
Akero Therapeutics reports financial results in USD
What is the latest annual profit for Akero Therapeutics?
The latest annual profit of Akero Therapeutics is USD -252.06M
What is the registered address of Akero Therapeutics?
The registered address for Akero Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Akero Therapeutics website address?
The website address for Akero Therapeutics is www.akerotx.com
Which industry sector does Akero Therapeutics operate in?
Akero Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Your Recent History

BIT
1AKRO
Akero Therapeutics
Delayed Upgrade Clock
ADVFN Logo
ADVFN UK
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads